Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.
Advanced stages of NAFLD were more commonly seen in people whose mothers had obesity or overweight during pregnancy.
People with fatty liver disease and advanced fibrosis also had a greater incidence of diabetes.
The MAFLD criteria for diagnosis was linked to higher all-cause and cardiovascular mortality.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
Study finds that lean people with NAFLD had a higher risk for liver events, cancer and mortality.
People doing more than 300 minutes of physical activity per week nearly halved their risk for NAFLD.
Mice that performed modest exercise were less likely to show signs of inflammation, cell aging and liver cancer.
If your previous treatment for hep C resulted in failure, can you undergo treatment again? This question, and others, answered here.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
What is the difference between a liver biopsy and a Fibroscan?
These recommendations are based on the World Health Organization’s guidelines.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
No significant links were found between liver stiffness prior to antiviral treatment and cirrhosis, liver cancer or transplants or death.
A daily dose of the growth factor analogue administered over 24 weeks also aided in NASH resolution.
Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.